Arimidex (anastrozole) is now approved as FIRST-LINE therapy of advanced or metastatic breast cancer
October 2000
Arimidex (anastrozole) is now approved as FIRST-LINE therapy of advanced or metastatic breast cancer.
Until now, Arimidex was approved only as second-line therapy...for when breast cancer progresses despite treatment with tamoxifen.
But recent studies show that Arimidex works at least as well as tamoxifen. It may even halt tumor growth longer than tamoxifen.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote